221 related articles for article (PubMed ID: 24838242)
1. Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua.
Lin YC; Li L; Makarova AV; Burgers PM; Stone MP; Lloyd RS
J Biol Chem; 2014 Jun; 289(26):18497-506. PubMed ID: 24838242
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct.
Lin YC; Li L; Makarova AV; Burgers PM; Stone MP; Lloyd RS
Carcinogenesis; 2014 Jul; 35(7):1461-8. PubMed ID: 24398669
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerase ΞΆ limits chromosomal damage and promotes cell survival following aflatoxin exposure.
Lin YC; Owen N; Minko IG; Lange SS; Tomida J; Li L; Stone MP; Wood RD; McCullough AK; Lloyd RS
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13774-13779. PubMed ID: 27849610
[TBL] [Abstract][Full Text] [Related]
4. Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
[TBL] [Abstract][Full Text] [Related]
5. The aflatoxin B
Minko IG; Kellum AH; Stone MP; Lloyd RS
Environ Mol Mutagen; 2024 Apr; 65 Suppl 1(Suppl 1):9-13. PubMed ID: 37303259
[TBL] [Abstract][Full Text] [Related]
6. DNA damage checkpoint response to aflatoxin B1.
Engin AB; Engin A
Environ Toxicol Pharmacol; 2019 Jan; 65():90-96. PubMed ID: 30594067
[TBL] [Abstract][Full Text] [Related]
7. Mutational spectra of aflatoxin B
Chawanthayatham S; Valentine CC; Fedeles BI; Fox EJ; Loeb LA; Levine SS; Slocum SL; Wogan GN; Croy RG; Essigmann JM
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3101-E3109. PubMed ID: 28351974
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.
McCullough AK; Lloyd RS
DNA Repair (Amst); 2019 May; 77():76-86. PubMed ID: 30897375
[TBL] [Abstract][Full Text] [Related]
9. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.
Smela ME; Hamm ML; Henderson PT; Harris CM; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6655-60. PubMed ID: 12011430
[TBL] [Abstract][Full Text] [Related]
10. DNA damage by mycotoxins.
Wang JS; Groopman JD
Mutat Res; 1999 Mar; 424(1-2):167-81. PubMed ID: 10064859
[TBL] [Abstract][Full Text] [Related]
11. Bypass of aflatoxin B1 adducts by the Sulfolobus solfataricus DNA polymerase IV.
Banerjee S; Brown KL; Egli M; Stone MP
J Am Chem Soc; 2011 Aug; 133(32):12556-68. PubMed ID: 21790157
[TBL] [Abstract][Full Text] [Related]
12. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Characterization of
Jaruga P; Tomar R; Kant M; Vartanian V; Sexton B; Rizzo CJ; Turesky RJ; Stone MP; Lloyd RS; Dizdaroglu M
ACS Omega; 2023 Apr; 8(16):14841-14854. PubMed ID: 37125130
[TBL] [Abstract][Full Text] [Related]
14. An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot.
Kobertz WR; Wang D; Wogan GN; Essigmann JM
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9579-84. PubMed ID: 9275165
[TBL] [Abstract][Full Text] [Related]
15. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action.
Moore MM; Schoeny RS; Becker RA; White K; Pottenger LH
Crit Rev Toxicol; 2018 Apr; 48(4):312-337. PubMed ID: 29431554
[TBL] [Abstract][Full Text] [Related]
16. DNA Sequence Modulates the Efficiency of NEIL1-Catalyzed Excision of the Aflatoxin B
Tomar R; Minko IG; Kellum AH; Voehler MW; Stone MP; McCullough AK; Lloyd RS
Chem Res Toxicol; 2021 Mar; 34(3):901-911. PubMed ID: 33595290
[TBL] [Abstract][Full Text] [Related]
17. Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice.
Chou MW; Chen W
J Nutr; 1997 Feb; 127(2):210-7. PubMed ID: 9039820
[TBL] [Abstract][Full Text] [Related]
18. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
Yu MW; Chiang YC; Lien JP; Chen CJ
Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
[TBL] [Abstract][Full Text] [Related]
19. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
20. A high pressure liquid chromatography study on the removal of DNA-bound aflatoxin B1 in rat liver and in vitro.
Hertzog PJ; Lindsay Smith JR; Garner RC
Carcinogenesis; 1980 Sep; 1(9):787-93. PubMed ID: 11219870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
